Newmarket Strategy acquires Visible Analytics to complete its full-service market access offer
Newmarket Strategy, a specialist healthcare and life sciences consultancy, announces today the successful acquisition of Visible Analytics, experts in Health Economics and Outcomes Research (HEOR) and data analytics.
The partnership enhances Newmarket’s position as the UK’s leading independent provider of health policy and market access advice to the life sciences sector, adding renowned technical capabilities. Clients will benefit from a comprehensive market access offer, delivering the specialist skills needed to ensure quicker and more successful commercialisation of their products. The company’s offer to clients will now combine commercial strategy, policy, reimbursement, HEOR, market entry and value communications.
Ed Jones, CEO of Newmarket Strategy, said: “We are thrilled to welcome Visible Analytics’ deep knowledge and technical skills to our growing team. Our mission is to provide innovators worldwide with outstanding advice so that more patients get quicker access to the best healthcare. VA’s exceptional team of high calibre individuals is consistently recognised by clients, in a field which fits directly alongside our existing capabilities, enhancing our impact.”
On behalf of Visible Analytics and its Founders, Edit Remak, Senior Partner at Visible Analytics said: “Our whole team is excited about the extended impact our joint capabilities may offer our clients across the product lifecycle. Joining Newmarket Strategy is a big milestone for us, aligning our evidence driven approach and scientific know-how with Newmarket’s commercial and policy insight.”
About Newmarket Strategy
- A market access and health policy consultancy, Newmarket Strategy was founded in 2021 by former Health Minister, Lord O’Shaughnessy, former Government health adviser, Ed Jones, and HTA expert, Berkeley Greenwood.
- The business was joined in 2023 by former NHS England Commercial Medicines Director and Interim Chief Commercial Officer, Blake Dark, who leads its Value & Access practice. Its Chief Clinical Officer is renowned oncologist and former Head of the NHS Cancer Drugs Fund, Professor Peter Clark, while its Strategic Government Affairs practice is led by former No10 Downing Street Health & Life Sciences adviser, Bill Morgan.
- With offices in London, Newmarket Strategy employs more than 40 people working for clients across pharmaceuticals, medtech and healthcare services – supporting them to successfully commercialise their solutions in the UK and other priority markets.
- Newmarket is backed by US Private Equity firm, Baird Capital, who took a minority stake in the business in January 2025.
About Visible Analytics
- VA provides a full service offering in health economics, health technology assessment (HTA) and related activities. Its work is guided by professional and personal integrity and driven by intellectual curiosity, scientific rigour and commitment to clients.
- Its team of immensely qualified health economics, statisticians and medical writers has substantial experience in economic modelling, clinical trial analysis, data analytics, value communication, systematic reviews and evidence synthesis.
- It was founded in 2018 by like-minded partners – Edit Remak MSc PhD, Noemi Muszbek MSc, Prof Neil Hawkins, Prof David Scott and Prof Keith Abrams. They are all maintaining their commitment to VA and their client-facing roles.
- The firm maintains offices in Oxford, UK and Budapest, Hungary – serving global pharmaceutical and life sciences companies in a range of therapy areas including oncology and rare disease.